DELINEATION OF SPATIAL TISSUE SIGNATURES OF IMMUNOTHERAPY RESPONSE GROUPS IN NON-SMALL CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Kulasinghe, Arutha [1 ]
Monkman, James [1 ]
Kim, Honesty [2 ]
Mayer, Aaron [2 ]
Mehdi, Ahmed [1 ]
Cumberbatch, Marie [3 ]
Bhagat, Milan [3 ]
Schneider, Fabian [4 ]
Thaagard, Jeppe [4 ]
Mansfield, James [4 ]
Ladwa, Rahul [5 ]
Mueller, Scott [6 ]
Adams, Mark [7 ]
O'byrne, Kenneth [5 ]
机构：
[1] Univ Queensland, Brisbane, Qld, Australia
[2] Enable Med, Menlo Pk, CA USA
[3] Tristar Technol, London, DC, England
[4] Visiopharm, Horsholm, Denmark
[5] Princess Alexandra Hosp, Brisbane, Qld, Australia
[6] Univ Melbourne, Melbourne, Vic, Australia
[7] Queensland Univ Technol, Brisbane, Qld, Australia
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0118
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
118
引用
收藏
页码：A130 / A130
页数：1
相关论文
共 50 条
  • [31] Clinical implications of mixed response on prognosis of non-small cell lung cancer (NSCLC) patients treated with Immunotherapy
    Lee, Seyoung
    Um, Taegyu
    Lee, Jeeyeon
    Kim, Peter Haseok
    Yadav, Monica
    Chuchuca, Maria J.
    Chung, Liam Il-Young
    Chae, Young Kwang
    CANCER RESEARCH, 2024, 84 (06)
  • [32] Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review
    Indini, Alice
    Rijavec, Erika
    Grossi, Francesco
    CANCERS, 2021, 13 (08)
  • [33] Tumor microenvironment assessment-based signatures for predicting response to immunotherapy in non-small cell lung cancer
    Wu, Jiani
    Wang, Yuanyuan
    Huang, Zhenhua
    Wu, Jingjing
    Sun, Huiying
    Zhou, Rui
    Qiu, Wenjun
    Ye, Zilan
    Fang, Yiran
    Huang, Xiatong
    Wu, Jianhua
    Bin, Jianping
    Liao, Yulin
    Shi, Min
    Wang, Jiguang
    Liao, Wangjun
    Zeng, Dongqiang
    ISCIENCE, 2024, 27 (12)
  • [34] THE M6A SIGNATURES INDICATED IMMUNOTHERAPY RESPONSE AND CLINICAL PROGNOSIS OF NON-SMALL CELL LUNG CANCER
    Peng, Z.
    CHEST, 2022, 161 (06) : 335A - 335A
  • [35] Novel machine learning (ML) algorithm to predict immunotherapy response in small cell (SCLC) and non-small cell (NSCLC) lung cancer
    Sharma, L.
    Choi, S.
    Balaji, V.
    Joshi, A.
    Mporas, I.
    Shi, J.
    Zhao, Y.
    Tailor, V.
    Powell, G.
    Alrifai, D.
    Shah, R.
    Waters, J. S. C.
    Adeleke, O. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S261 - S261
  • [36] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
  • [37] Micrometastases in non-small cell lung cancer (NSCLC)
    Passlick, B
    LUNG CANCER, 2001, 34 : S25 - S29
  • [38] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [39] Genotyping Non-Small Cell Lung Cancer (NSCLC)
    Delia Campos-Parra, Alma
    Cruz-Rico, Graciela
    Arrieta, Oscar
    GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (01): : 35 - 44
  • [40] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    Investigational New Drugs, 2000, 18 : 29 - 42
12345